PDL BioPharma (PDLI)
PDL BioPharma Dividend Yield: 9.20%
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
PDLI Dividend Yield Rankings
| Overall | 97th percentile | 110 of 4657 |
| Sector | 99th percentile | 2 of 525 in Healthcare |
| Industry | 99th percentile | 1 of 163 in Biotechnology |
PDLI Dividend Yield Range, Past 5 Years
| Minimum | 0.00% | Jun 2007 |
| Maximum | 68.77% | Dec 2008 |
| Average | 23.72% |
About Dividend Yield
The dividend yield is the sum company's annual dividends per share, divided by the current price per share. It is often expressed as a percentage. It the reciprocal of the price/dividend ratio. By investing in a company with a high dividend yield, investors can secure a relatively stable cash flow. However, it is important to note that sometimes dividend yields are high when a company is facing financial trouble, and the company may cut the dividend in the near future.
For example, if a stock trades at $36 and pays $1.80 in dividends over the course of one year ($.45 per quarter), the company's dividend yield is 5%.
Learn More
You may also be interested in these PDLI related companies
PDLI News
$PDLI http://stks.co/3wcN approaching breakout point on a volume spike... http://stks.co/3wcO
about 4 days ago by TraderHR
about 4 days ago by TraderHR
@Fibline Nice list yessir, liking $SLXP from last week, bought $ARIA today, like the divy on $PDLI, hope it breaks up
about 12 days ago by harmongreg
about 12 days ago by harmongreg
@Legacy_Trades you still like $PDLI here? TA looking up, but would appreciate your FA view.
about 15 days ago by gtlackey
about 15 days ago by gtlackey
Watchlist 5/7.Careful tday but following charts look ready for a small run.$KGJI,$AFFX,$GEOY,$NAVG,$PDLI,$VNET.Look for intraday weakness.
about 19 days ago by traderNC
about 19 days ago by traderNC
PDL BioPharma's CEO Discusses Q1 2012 Results - Earnings Call Transcript
May 03, 6:52PM Seeking Alpha
May 03, 6:52PM Seeking Alpha
Listen to $PDLI Q1 2012 earnings call - live at 04:30 PM, ondemand after - http://stks.co/3eza
about 23 days ago by earningscast
about 23 days ago by earningscast
PDL BioPharma to Announce First Quarter 2012 Financial Results on May 3, 2012
Apr 27, 5:56PM PR Newswire
Apr 27, 5:56PM PR Newswire
PDL BioPharma Provides First Quarter 2012 Royalty Revenue Guidance of $77 Million
Mar 08, 4:02PM PR Newswire
Mar 08, 4:02PM PR Newswire
$PDLI forms bearish "Double Top" chart pattern. http://stks.co/2haG
about 81 days ago by RecogniaEvents
about 81 days ago by RecogniaEvents
PDL BioPharma Announces Conversion Rate Adjustments for Its Convertible Notes
Mar 05, 4:02PM PR Newswire
Mar 05, 4:02PM PR Newswire
7 High Profitable Healthcare Dividend Stocks With Fantastic Yields + http://stks.co/2dw4 + $PDLI $AZN $PMD $GSK $BMY $NVO $SHPGY
about 85 days ago by DividendYield
about 85 days ago by DividendYield
PDL BioPharma's CEO Discusses Q4 2011 Results - Earnings Call Transcript
Feb 23, 10:46PM Seeking Alpha
Feb 23, 10:46PM Seeking Alpha
Listen to $PDLI Q4 2011 earnings call - live at 04:30 PM, ondemand after - http://stks.co/2XOK
about 93 days ago by earningscast
about 93 days ago by earningscast
$PDLI Reports Q4 EPS $0.24 vs $0.24 Est; Revenues $72.8M vs $72.85M Est
about 93 days ago by Benzinga
about 93 days ago by Benzinga
PDL BioPharma Announces Fourth Quarter and Full Year 2011 Financial Results
Feb 23, 4:00PM PR Newswire
Feb 23, 4:00PM PR Newswire
PDL BioPharma to Announce Fourth Quarter and Full Year 2011 Financial Results on February 23, 2012
Feb 16, 7:00AM PR Newswire
Feb 16, 7:00AM PR Newswire
Seth Klarman's Baupost Group drastically reduces PDL BioPharma $PDLI position http://stks.co/2LmR
about 106 days ago by marketfolly
about 106 days ago by marketfolly
PDL BioPharma to Present at the 14th Annual BIO CEO & Investor Conference
Feb 07, 7:00AM PR Newswire
Feb 07, 7:00AM PR Newswire
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| PDLI | 6.48 | -0.01 | -0.15% | 906.42M |
| PCLN | 652.88 | -16.09 | -2.41% | 32.51B |
| PCL | 36.71 | -0.31 | -0.84% | 5.925B |
| PCCC | 9.00 | +0.04 | +0.45% | 237.96M |
| PCA | 12.54 | +0.02 | +0.16% | |
| PC | 6.49 | -0.19 | -2.84% | 15.01B |
| PBY | 11.07 | +0.10 | +0.91% | 583.94M |
| PBT | 18.93 | +0.13 | +0.69% | 882.33M |
| PBR | 19.40 | +0.15 | +0.78% | 72.19B |
| PBNY | 7.93 | -0.11 | -1.37% | 300.47M |